John Cox is President and Chief Executive Officer of Dyne Therapeutics, Inc. (DYN). The company reported total compensation of $2,076,868 for fiscal year 2025.
| Salary | $721,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $937,893 |
| Non-equity incentive plan | $410,970 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $7,005 |
| Total | $2,076,868 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Dyne Therapeutics, Inc. filed April 23, 2026, accession 0001193125-26-173655.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $721,000 | $0 | $0 | $937,893 | $410,970 | $0 | $7,005 | $2,076,868 |
| FY2024 | President and Chief Executive Officer | $536,986 | $0 | $4,277,632 | $15,533,800 | $339,510 | $0 | $796 | $20,688,724 |
Totals as disclosed in each year's own compensation disclosure for Dyne Therapeutics, Inc..
| Peer-group chief executive median | $8,883,661 |
|---|---|
| Difference from that median | $-6,806,792 |
| Percentile within the disclosed peer group | 1st |
| Peers with a disclosed figure | 18 |
Medians and percentiles are computed across the peer group Dyne Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Erick Lucera | Chief Financial Officer and Treasurer | $2,695,986 |
| John Cox this page | President and Chief Executive Officer | $2,076,868 |
| Johanna Friedl-Naderer | Chief Commercial Officer | $1,086,420 |
| Douglas Kerr | Chief Medical Officer | $1,057,598 |
| Oxana Beskrovnaya | Chief Innovation Officer; Former Chief Scientific Officer | $992,628 |
| Richard Scalzo | Former Senior Vice President, Head of Finance and Administration | $727,638 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Dyne Therapeutics, Inc. compensation brief.
John Cox's compensation sits inside Dyne Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.